Table 3: Summarizing efficacy results of the 2 regimens.

FLOX arm3-week arm value

Partial responses3 (12.5%) 2 (16%) .23
Stable disease5 (21%) 5 (21%) .5
Clinical benefit3/8 (37.5%) 4/8 (50%) .19